Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Endophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty.

Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC, Hsu J, Regillo CD, Ayres BD, Hammersmith KM, Nagra PK, Raber IM, Rapuano CJ, Syed ZA.

Am J Ophthalmol. 2019 Sep 19. pii: S0002-9394(19)30393-9. doi: 10.1016/j.ajo.2019.08.003. [Epub ahead of print] No abstract available.

PMID:
31543217
2.

Subfoveal Neurosensory Detachment Flattening and Observe (SNF-Ob): A Novel Approach in Diabetic Macular Edema Management: A Potential Cost-Effective Treatment Strategy to Be Explored.

Sharma A, Parachuri N, Kumar N, Kuppermann BD, Bandello F, Loewenstein A, Regillo CD.

Ophthalmol Retina. 2019 Nov;3(11):1009-1011. doi: 10.1016/j.oret.2019.06.016. Epub 2019 Jul 10. No abstract available.

PMID:
31451440
3.

Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression.

Sharma A, Kumar N, Parachuri N, Kuppermann BD, Bandello F, Regillo CD.

Eye (Lond). 2019 Jun 5. doi: 10.1038/s41433-019-0479-y. [Epub ahead of print] No abstract available.

PMID:
31165769
4.

Endophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty.

Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC, Hsu J, Regillo CD, Ayres BD, Hammersmith KM, Nagra PK, Raber IM, Rapuano CJ, Syed ZA.

Am J Ophthalmol. 2019 Sep;205:82-90. doi: 10.1016/j.ajo.2019.05.004. Epub 2019 May 10.

PMID:
31082349
5.

Comparing 33-Gauge versus 30-Gauge Needles for Intravitreal Injections.

Aderman CM, Rahimy E, Obeid A, Gao X, Hsu J, Garg SJ, Regillo CD, Gupta OP, Chiang A.

Ophthalmol Retina. 2018 Oct;2(10):1078-1079. doi: 10.1016/j.oret.2018.05.003. Epub 2018 Aug 29. No abstract available.

PMID:
31047499
6.

Displacement of Submacular Hemorrhage With Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade in the Setting of Myopic Degeneration.

Shields RA, Tang PH, Regillo CD, Silva RA.

Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):257-259. doi: 10.3928/23258160-20190401-11.

PMID:
30998250
7.

Pars Plana Vitrectomy Alone for Primary Rhegmatogenous Retinal Detachments Associated With Inferior Breaks in Phakic Eyes.

Talcott KE, Obeid A, Gao X, Adika A, Regillo CD.

Ophthalmic Surg Lasers Imaging Retina. 2019 Mar 1;50(3):153-158. doi: 10.3928/23258160-20190301-04.

PMID:
30893448
8.

Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial.

London NJS, Kaiser RS, Khan MA, Alshareef RA, Khuthaila M, Shahlaee A, Obeid A, London VA, DeCroos FC, Gupta OP, Hsu J, Vander JF, Spirn MJ, Regillo CD.

Br J Ophthalmol. 2019 Sep;103(9):1306-1313. doi: 10.1136/bjophthalmol-2018-312839. Epub 2018 Oct 31.

PMID:
30381390
9.

Reply.

Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J.

Am J Ophthalmol. 2018 Dec;196:211-212. doi: 10.1016/j.ajo.2018.08.031. Epub 2018 Sep 28. No abstract available.

PMID:
30274784
10.

Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.

Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, Fineman MS, Regillo CD, Maguire JI, Garg SJ, Hsu J.

Ophthalmology. 2019 Mar;126(3):407-413. doi: 10.1016/j.ophtha.2018.07.027. Epub 2018 Aug 2.

PMID:
30077614
11.

Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J; Wills Post Injection Endophthalmitis (PIE) Study Group.

Am J Ophthalmol. 2018 Oct;194:1-6. doi: 10.1016/j.ajo.2018.06.022. Epub 2018 Jul 6.

PMID:
29981738
12.

Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion.

Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J.

Br J Ophthalmol. 2019 Jan;103(1):55-59. doi: 10.1136/bjophthalmol-2018-311898. Epub 2018 Mar 22.

PMID:
29567791
13.

PARS PLANA VITRECTOMY WITH ANTERIOR CHAMBER VERSUS GORE-TEX SUTURED POSTERIOR CHAMBER INTRAOCULAR LENS PLACEMENT: Long-Term Outcomes.

Khan MA, Gupta OP, Pendi K, Chiang A, Vander J, Regillo CD, Hsu J.

Retina. 2019 May;39(5):860-866. doi: 10.1097/IAE.0000000000002042.

PMID:
29346243
14.

Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease.

Khan MA, Kuley A, Riemann CD, Berrocal MH, Lakhanpal RR, Hsu J, Sivalingam A, Ho AC, Regillo CD.

Ophthalmology. 2018 Mar;125(3):423-431. doi: 10.1016/j.ophtha.2017.09.013. Epub 2017 Nov 13.

PMID:
29146307
15.

Reply.

DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD.

Am J Ophthalmol. 2017 Oct;182:205-206. doi: 10.1016/j.ajo.2017.07.016. Epub 2017 Aug 10. No abstract available.

PMID:
28803629
16.

Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.

Yaspan BL, Williams DF, Holz FG, Regillo CD, Li Z, Dressen A, van Lookeren Campagne M, Le KN, Graham RR, Beres T, Bhangale TR, Honigberg LA, Smith A, Henry EC, Ho C, Strauss EC; MAHALO Study Investigators.

Sci Transl Med. 2017 Jun 21;9(395). pii: eaaf1443. doi: 10.1126/scitranslmed.aaf1443.

PMID:
28637922
17.

Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial.

DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD.

Am J Ophthalmol. 2017 Aug;180:142-150. doi: 10.1016/j.ajo.2017.06.002. Epub 2017 Jun 15.

PMID:
28624325
18.

Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert Panel.

Regillo CD, Callanan DG, Do DV, Fine HF, Holekamp NM, Kuppermann BD, Singer MA, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2017 Apr 1;48(4):291-301. doi: 10.3928/23258160-20170329-03.

PMID:
28419394
19.

27-GAUGE VITRECTOMY WOUND INTEGRITY: A Randomized Pilot Study Comparing Angled Versus Straight Entry in Fluid-Filled Vitrectomized Eyes.

Khan MA, Durrani AK, Hsu J, Regillo CD.

Retina. 2018 Apr;38(4):678-683. doi: 10.1097/IAE.0000000000001598.

PMID:
28358751
20.

Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion.

Chiang A, Cohen MN, Houston SK, Juhn A, Ho AC, Regillo CD, Vander JF.

Can J Ophthalmol. 2017 Feb;52(1):137-138. doi: 10.1016/j.jcjo.2016.12.001. No abstract available.

PMID:
28237140
21.

Reply.

Rayess N, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J, Rahimy E.

Am J Ophthalmol. 2017 Apr;176:258-259. doi: 10.1016/j.ajo.2017.01.022. Epub 2017 Feb 10. No abstract available.

PMID:
28190510
22.

The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good.

Ho AC, Albini TA, Brown DM, Boyer DS, Regillo CD, Heier JS.

JAMA Ophthalmol. 2017 Mar 1;135(3):268-273. doi: 10.1001/jamaophthalmol.2016.5314. Review.

PMID:
28114653
23.

Treat-and-Extend Regimen for Macular Edema Secondary to Central Retinal Vein Occlusion: 12-Month Results.

Rahimy E, Rayess N, Brady CJ, Regillo CD.

Ophthalmol Retina. 2017 Mar - Apr;1(2):118-123. doi: 10.1016/j.oret.2016.10.014. Epub 2016 Dec 23.

PMID:
31047268
24.

MINIMAL ENDOILLUMINATION LEVELS AND DISPLAY LUMINOUS EMITTANCE DURING THREE-DIMENSIONAL HEADS-UP VITREORETINAL SURGERY.

Adam MK, Thornton S, Regillo CD, Park C, Ho AC, Hsu J.

Retina. 2017 Sep;37(9):1746-1749. doi: 10.1097/IAE.0000000000001420.

PMID:
27902640
25.

RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.

Shields CL, Say EAT, Pefkianaki M, Regillo CD, Caywood EH, Jabbour PM, Shields JA.

Retina. 2017 Aug;37(8):1441-1450. doi: 10.1097/IAE.0000000000001382.

PMID:
27787452
26.

Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion.

Cohen MN, Houston SK, Juhn A, Ho AC, Regillo CD, Vander J, Chiang A.

Can J Ophthalmol. 2016 Oct;51(5):342-347. doi: 10.1016/j.jcjo.2016.02.001. Epub 2016 Sep 3.

PMID:
27769324
27.

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.

Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J.

Am J Ophthalmol. 2016 Nov;171:47-52. doi: 10.1016/j.ajo.2016.08.026. Epub 2016 Aug 24.

PMID:
27567889
28.

Baseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin.

Jackson TL, Regillo CD, Girach A, Dugel PU; MIVI-TRUST Study Group.

Ophthalmic Surg Lasers Imaging Retina. 2016 Aug 1;47(8):716-23. doi: 10.3928/23258160-20160808-04.

PMID:
27548448
29.

Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications.

Shieh WS, Sridhar J, Hong BK, Maguire JI, Rahimy E, Shahlaee A, Ho AC, Hsu J, Regillo CD, Chiang A.

Semin Ophthalmol. 2017;32(5):614-619. doi: 10.3109/08820538.2016.1139738. Epub 2016 Jul 1.

PMID:
27367495
30.

The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema.

Moshfeghi DM, Kaiser PK, Michels S, Midena E, Kitchens JW, Prenner JL, Regillo CD, Reichel E.

Ophthalmic Surg Lasers Imaging Retina. 2016 Jun;47(6 Suppl):S4-S14. doi: 10.3928/23258160-20160415-01.

PMID:
27348433
31.

Reply.

Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J.

Am J Ophthalmol. 2016 Aug;168:291-292. doi: 10.1016/j.ajo.2016.05.014. Epub 2016 Jun 4. No abstract available.

PMID:
27270363
32.

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials.

Wykoff CC, Elman MJ, Regillo CD, Ding B, Lu N, Stoilov I.

Ophthalmology. 2016 Aug;123(8):1716-1721. doi: 10.1016/j.ophtha.2016.04.004. Epub 2016 May 18.

33.

Reply.

Khan MA, Shahlaee A, Hsu J, Sivalingam A, Regillo CD, Ho AC, Toussaint B, Riemann CD, Dugel PU, Lakhanpal RR, Berrocal MH.

Am J Ophthalmol. 2016 Apr;164:145-6. doi: 10.1016/j.ajo.2016.02.010. Epub 2016 Mar 2. No abstract available.

PMID:
26944756
34.

Reply.

Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC.

Am J Ophthalmol. 2016 Apr;164:148-9. doi: 10.1016/j.ajo.2016.01.009. Epub 2016 Feb 17. No abstract available.

PMID:
26897104
35.

Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.

Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J.

Am J Ophthalmol. 2016 Apr;164:118-27.e2. doi: 10.1016/j.ajo.2015.12.030. Epub 2015 Dec 31.

PMID:
26748058
36.

TREATMENT OUTCOMES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH INITIAL VISION BETTER THAN 20/40 USING A TREAT-AND-EXTEND REGIMEN.

Rahimy E, Rayess N, Ho AC, Regillo CD.

Retina. 2016 May;36(5):875-80. doi: 10.1097/IAE.0000000000000814.

PMID:
26630316
37.

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.

Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA 3rd; American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel.

JAMA Ophthalmol. 2016 Jan;134(1):95-9. doi: 10.1001/jamaophthalmol.2015.4110.

PMID:
26512939
38.

Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.

Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC.

Am J Ophthalmol. 2016 Jan;161:36-43.e1-2. doi: 10.1016/j.ajo.2015.09.024. Epub 2015 Sep 28.

PMID:
26429584
39.

Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal Detachment.

Setlur VJ, Rayess N, Garg SJ, Hsu J, Luo CK, Regillo CD, Fineman MS, Sivalingam A.

Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug;46(7):702-7. doi: 10.3928/23258160-20150730-03.

PMID:
26247450
40.

Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration.

Regillo CD, Busbee BG, Ho AC, Ding B, Haskova Z.

Am J Ophthalmol. 2015 Nov;160(5):1014-1023.e2. doi: 10.1016/j.ajo.2015.07.034. Epub 2015 Jul 29.

41.

Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind.

Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Brown GC, Haller JA, Regillo CD, Del Priore LV, Arditi A, Geruschat DR, Greenberg RJ; Argus II Study Group.

Ophthalmology. 2015 Aug;122(8):1547-54. doi: 10.1016/j.ophtha.2015.04.032. Epub 2015 Jul 8.

42.

INFLUENCE OF VITREOMACULAR INTERFACE ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY USING TREAT AND EXTEND TREATMENT PROTOCOL FOR AGE-RELATED MACULAR DEGENERATION (VINTREX).

Houston SK 3rd, Rayess N, Cohen MN, Ho AC, Regillo CD.

Retina. 2015 Sep;35(9):1757-64. doi: 10.1097/IAE.0000000000000663.

PMID:
26110596
43.

Contemporary Management of Rhegmatogenous Retinal Detachment Due to Giant Retinal Tears: A Consecutive Case Series.

Pitcher JD 3rd, Khan MA, Storey PP, Hsiao-Fang-Yen N, Dollin ML, Hsu J, Ho AC, Regillo CD, Garg SJ.

Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):566-70. doi: 10.3928/23258160-20150521-08.

PMID:
26057760
44.

Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.

Salz DA, Pitcher JD 3rd, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ.

Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):439-44. doi: 10.3928/23258160-20150422-06.

PMID:
25970864
45.

Speculum versus Bimanual Lid Retraction during Intravitreal Injection.

Rahimy E, Fineman MS, Regillo CD, Spirn MJ, Hsu J, Kaiser RS, Maguire JI, Brown GC, Chiang A.

Ophthalmology. 2015 Aug;122(8):1729-30. doi: 10.1016/j.ophtha.2015.02.001. Epub 2015 Feb 26. No abstract available.

PMID:
25726752
46.

PROSPECTIVE EVALUATION OF VISUAL ACUITY AGREEMENT BETWEEN STANDARD EARLY TREATMENT DIABETIC RETINOPATHY STUDY CHART AND A HANDHELD EQUIVALENT IN EYES WITH RETINAL PATHOLOGY.

Rahimy E, Reddy S, DeCroos FC, Khan MA, Boyer DS, Gupta OP, Regillo CD, Haller JA.

Retina. 2015 Aug;35(8):1680-7. doi: 10.1097/IAE.0000000000000518.

PMID:
25719987
47.

Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review.

DeCroos FC, Todorich B, Alshareef R, Khuthaila M, Fekrat S, Ho AC, Regillo CD, Spirn MJ.

J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):461-8. doi: 10.4103/2008-322X.150825.

48.

Reply: To PMID 24531021.

Chang W, Garg SJ, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC, Maturi R.

Am J Ophthalmol. 2015 Feb;159(2):404-5. doi: 10.1016/j.ajo.2014.10.022. No abstract available.

PMID:
25542554
49.

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.

Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R.

Lancet. 2015 Feb 7;385(9967):509-16. doi: 10.1016/S0140-6736(14)61376-3. Epub 2014 Oct 15.

PMID:
25458728
50.

Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema.

Rayess N, Rahimy E, Ying GS, Bagheri N, Ho AC, Regillo CD, Vander JF, Hsu J.

Am J Ophthalmol. 2015 Jan;159(1):85-91.e1-3. doi: 10.1016/j.ajo.2014.09.033. Epub 2014 Sep 28.

PMID:
25261844

Supplemental Content

Loading ...
Support Center